Literature DB >> 33863997

The effect of age on the association between diabetes and mortality in adult patients with COVID-19 in Mexico.

Orison O Woolcott1, Juan P Castilla-Bancayán2,3.   

Abstract

Diabetes is associated with severe COVID-19 and mortality. The aim of the present study was to determine the effect of age on the association between diabetes and mortality in patients with laboratory-confirmed COVID-19 in Mexico. This retrospective cohort study involved patients aged 20 years or older with symptoms of viral respiratory disease who were screened for SARS-CoV-2 infection across the System of Epidemiological Surveillance of Viral Respiratory Disease in Mexico from January 1 through November 4, 2020. Cox proportional-hazard regression was used to calculate the hazard ratio for 28-day mortality and its 95% confidence interval (CI). Among 757,210 patients with COVID-19 (outpatients and inpatients), 120,476 (16%) had diabetes and 80,616 died. Among 878,840 patients without COVID-19 (those who tested negative for SARS-CoV-2 infection), 88,235 (10.0%) had diabetes and 20,134 died. Among patients with COVID-19, diabetes was associated with a hazard ratio for death of 1.49 (95% CI 1.47-1.52), adjusting for age, sex, smoking habit, obesity, hypertension, immunodeficiency, and cardiovascular, pulmonary, and chronic renal disease. The strength of the association decreased with age (trend test: P = 0.004). For example, the adjusted hazard ratio for death was 3.12 (95% CI 2.86-3.40) for patients 20-39 years of age; in contrast, the adjusted hazard ratio of death for patients 80 years of age or older was 1.11 (95% CI 1.06-1.16). The adjusted hazard ratios were 1.66 (95% CI 1.58-1.74) in outpatients and 1.14 (95% CI 1.12-1.16) in inpatients. In hospitalized patients 80 years of age or older, no association was observed between diabetes and COVID-19-related mortality (adjusted hazard ratio: 1.03; 95% CI 0.98-1.08). Among patients without COVID-19, the adjusted hazard ratio for death was 1.78 (95% CI 1.73-1.84). In conclusion, in adult patients with COVID-19 in Mexico, the risk of death associated with diabetes decreased with age. No association between diabetes and mortality was observed among inpatients 80 years of age or older. Our findings should be verified in other populations.

Entities:  

Year:  2021        PMID: 33863997     DOI: 10.1038/s41598-021-88014-z

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  9 in total

Review 1.  Diabetes and SARS-CoV-2-Is There a Mutual Connection?

Authors:  Anna P Jedrzejak; Edyta K Urbaniak; Jadwiga A Wasko; Natalia Ziojla; Malgorzata Borowiak
Journal:  Front Cell Dev Biol       Date:  2022-06-13

2.  COVID-19 Propagation Model Based on Economic Development and Interventions.

Authors:  Fuzhong Nian; Yayong Shi; Jun Cao
Journal:  Wirel Pers Commun       Date:  2021-08-18       Impact factor: 1.671

3.  First and second COVID-19 waves in Brazil: A cross-sectional study of patients' characteristics related to hospitalization and in-hospital mortality.

Authors:  Felipe André Zeiser; Bruna Donida; Cristiano André da Costa; Gabriel de Oliveira Ramos; Juliana Nichterwitz Scherer; Nêmora Tregnago Barcellos; Ana Paula Alegretti; Maria Letícia Rodrigues Ikeda; Ana Paula Wernz C Müller; Henrique C Bohn; Ismael Santos; Luiza Boni; Rodolfo Stoffel Antunes; Rodrigo da Rosa Righi; Sandro José Rigo
Journal:  Lancet Reg Health Am       Date:  2021-11-01

4.  Association of Admission Blood Glucose Level with All-Cause Mortality According to Age in Patients with Community Acquired Pneumonia.

Authors:  Yejing Shen; Xiaowen Xu; Siming Meng; Meng Qin; Hailing Li; Dejie Chu; Cuixia Zheng
Journal:  Int J Gen Med       Date:  2021-11-06

5.  Impaired glucose regulation, SARS-CoV-2 infections and adverse COVID-19 outcomes.

Authors:  Sumith Roy; Ryan T Demmer
Journal:  Transl Res       Date:  2021-11-09       Impact factor: 7.012

Review 6.  Factors Associated for Mortality of Older People With COVID 19: A Systematic Review and Meta-analysis.

Authors:  H D W T Damayanthi; K I P Prabani; Ishanka Weerasekara
Journal:  Gerontol Geriatr Med       Date:  2021-12-01

7.  Association of underlying comorbidities and progression of COVID-19 infection amongst 2586 patients hospitalised in the National Capital Region of India: a retrospective cohort study.

Authors:  Rashmi Rana; Vivek Ranjan; Naveen Kumar; Parul Chugh; Kamini Khillan; Atul Gogia; Devinder Singh Rana; Nirmal Kumar Ganguly
Journal:  Mol Cell Biochem       Date:  2022-06-25       Impact factor: 3.842

8.  A new interventional home care model for COVID management: Virtual Covid IP.

Authors:  Jothydev Kesavadev; Anjana Basanth; Gopika Krishnan; Rebecca Vitale; Hari Parameswaran; Sajna Shijin; Sreelakshmi R; Sumesh Raj; Asha Ashik; Arun Shankar; Sameer Badarudeen; A V Raveendran; Indu Rajalakshmy; Geethu Sanal; Akhila Manoj; Remya Jose; Yaseen Unes; Sunitha Jothydev
Journal:  Diabetes Metab Syndr       Date:  2021-07-23

9.  Impact of Prediabetes and Type-2 Diabetes on Outcomes in Patients with COVID-19.

Authors:  Jasbir Makker; Haozhe Sun; Harish Patel; Nikhitha Mantri; Maleeha Zahid; Sudharsan Gongati; Sneha Galiveeti; Sharon W Renner; Sridhar Chilimuri
Journal:  Int J Endocrinol       Date:  2021-06-16       Impact factor: 3.257

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.